Watanobe, H <br/><br/>
Lack of involvement of the cholinergic mechanism in vasoactive intestinal peptide- and peptide-histidine methionine-induced growth hormone (GH) responses in acromegaly: comparison with the GH responses to thyrotropin-releasing hormone and GH-releasing hormone.  [electronic resource] 

 -  Neuropeptides  Aug 1994 
 - 85-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0143-4179 
<br/><br/><label>Standard No.: </label>10.1016/0143-4179(94)90047-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholine--physiology<br/>Acromegaly--physiopathology<br/>Adult<br/>Atropine--pharmacology<br/>Basal Metabolism<br/>Female<br/>Growth Hormone--metabolism<br/>Growth Hormone-Releasing Hormone--pharmacology<br/>Humans<br/>Male<br/>Middle Aged<br/>Peptide PHI--pharmacology<br/>Prolactin--metabolism<br/>Thyrotropin-Releasing Hormone--pharmacology<br/>Vasoactive Intestinal Peptide--pharmacology